PolyPid Other Stockholder Equity from 2010 to 2024
| PYPD Stock | USD 3.34 0.12 3.47% |
Other Stockholder Equity | First Reported 2013-12-31 | Previous Quarter 252.7 M | Current Value 261 M | Quarterly Volatility 77.9 M |
Check PolyPid financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PolyPid's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 1.6 M or Selling General Administrative of 5.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. PolyPid financial statements analysis is a perfect complement when working with PolyPid Valuation or Volatility modules.
PolyPid | Other Stockholder Equity |
Latest PolyPid's Other Stockholder Equity Growth Pattern
Below is the plot of the Other Stockholder Equity of PolyPid over the last few years. It is PolyPid's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PolyPid's overall financial position and show how it may be relating to other accounts over time.
| Other Stockholder Equity | 10 Years Trend |
|
Other Stockholder Equity |
| Timeline |
PolyPid Other Stockholder Equity Regression Statistics
| Arithmetic Mean | 75,714,043 | |
| Coefficient Of Variation | 154.62 | |
| Mean Deviation | 105,383,119 | |
| Median | 25,257,000 | |
| Standard Deviation | 117,068,605 | |
| Sample Variance | 13705.1T | |
| Range | 311.5M | |
| R-Value | 0.79 | |
| Mean Square Error | 5485.6T | |
| R-Squared | 0.63 | |
| Significance | 0.0004 | |
| Slope | 20,750,073 | |
| Total Sum of Squares | 191870.8T |
PolyPid Other Stockholder Equity History
About PolyPid Financial Statements
PolyPid stakeholders use historical fundamental indicators, such as PolyPid's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although PolyPid investors may analyze each financial statement separately, they are all interrelated. For example, changes in PolyPid's assets and liabilities are reflected in the revenues and expenses on PolyPid's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PolyPid. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Stockholder Equity | 236.2 M | 248 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:Check out the analysis of PolyPid Correlation against competitors. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.22) | Return On Assets (0.65) | Return On Equity (4.97) |
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.